Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 667

1.

A psychology of the human brain-gut-microbiome axis.

Allen AP, Dinan TG, Clarke G, Cryan JF.

Soc Personal Psychol Compass. 2017 Apr;11(4):e12309. doi: 10.1111/spc3.12309. Epub 2017 Apr 18.

2.

Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.

Mazzawi T, El-Salhy M.

Exp Biol Med (Maywood). 2017 Jul;242(13):1355-1362. doi: 10.1177/1535370217699537. Epub 2017 Mar 17.

3.

Dietary fiber in irritable bowel syndrome (Review).

El-Salhy M, Ystad SO, Mazzawi T, Gundersen D.

Int J Mol Med. 2017 Sep;40(3):607-613. doi: 10.3892/ijmm.2017.3072. Epub 2017 Jul 19.

4.

Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial.

Vincenzi M, Del Ciondolo I, Pasquini E, Gennai K, Paolini B.

J Transl Int Med. 2017 Jun 30;5(2):120-126. doi: 10.1515/jtim-2017-0004. eCollection 2017 Jun.

5.

Butyric acid - a well-known molecule revisited.

Borycka-Kiciak K, Banasiewicz T, Rydzewska G.

Prz Gastroenterol. 2017;12(2):83-89. doi: 10.5114/pg.2017.68342. Epub 2017 Jun 13. Review.

6.

Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System.

Ohlsson B.

Front Endocrinol (Lausanne). 2017 Jun 7;8:110. doi: 10.3389/fendo.2017.00110. eCollection 2017. Review.

7.

The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.

Ciampa BP, Reyes Ramos E, Borum M, Doman DB.

Gastroenterol Hepatol (N Y). 2017 Feb;13(2):104-115.

8.

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.

Kato T, Honda Y, Kurita Y, Iwasaki A, Sato T, Kessoku T, Uchiyama S, Ogawa Y, Ohkubo H, Higurashi T, Yamanaka T, Usuda H, Wada K, Nakajima A.

PLoS One. 2017 Apr 14;12(4):e0175626. doi: 10.1371/journal.pone.0175626. eCollection 2017.

9.

Gastroparesis and lipid metabolism-associated dysbiosis in Wistar-Kyoto rats.

Dalziel JE, Fraser K, Young W, McKenzie CM, Bassett SA, Roy NC.

Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G62-G72. doi: 10.1152/ajpgi.00008.2017. Epub 2017 Apr 13.

10.

Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.

Peters SA, Edogawa S, Sundt WJ, Dyer RB, Dalenberg DA, Mazzone A, Singh RJ, Moses N, Smyrk TC, Weber C, Linden DR, MacNaughton WK, Turner JR, Camilleri M, Katzka DA, Farrugia G, Grover M.

Am J Gastroenterol. 2017 Jun;112(6):913-923. doi: 10.1038/ajg.2017.48. Epub 2017 Mar 21.

11.

Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome.

Dlugosz A, Zakikhany K, Acevedo N, D'Amato M, Lindberg G.

Biomed Res Int. 2017;2017:9624702. doi: 10.1155/2017/9624702. Epub 2017 Jan 29.

12.

The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.

Iizuka K.

Nutrients. 2017 Feb 22;9(2). pii: E181. doi: 10.3390/nu9020181. Review.

13.

Irritable bowel syndrome and diet.

Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S.

Gastroenterol Rep (Oxf). 2017 Jan 20. pii: gow047. doi: 10.1093/gastro/gow047. [Epub ahead of print] Review.

14.

Can probiotics modulate human disease by impacting intestinal barrier function?

Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM.

Br J Nutr. 2017 Jan;117(1):93-107. doi: 10.1017/S0007114516004037. Review.

15.

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.

Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L.

World J Gastroenterol. 2016 Dec 28;22(48):10631-10642. doi: 10.3748/wjg.v22.i48.10631.

16.

Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel.

Yang C, Xiong Y, Zhang SS, An FM, Sun J, Zhang QL, Zhan Q.

World J Gastroenterol. 2016 Dec 28;22(48):10584-10591. doi: 10.3748/wjg.v22.i48.10584.

17.

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.

Ceuleers H, Van Spaendonk H, Hanning N, Heirbaut J, Lambeir AM, Joossens J, Augustyns K, De Man JG, De Meester I, De Winter BY.

World J Gastroenterol. 2016 Dec 21;22(47):10275-10286. doi: 10.3748/wjg.v22.i47.10275. Review.

18.

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes.

Domżał-Magrowska D, Kowalski MK, Szcześniak P, Bulska M, Orszulak-Michalak D, Małecka-Panas E.

Prz Gastroenterol. 2016;11(4):276-281. doi: 10.5114/pg.2016.57941. Epub 2016 Feb 16.

19.

Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.

Lee HJ, Choi JK, Ryu HS, Choi CH, Kang EH, Park KS, Min YW, Hong KS.

J Neurogastroenterol Motil. 2017 Jan 30;23(1):9-19. doi: 10.5056/jnm16124. Review.

20.

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

Piscaglia AC, Laterza L, Cesario V, Gerardi V, Landi R, Lopetuso LR, Calò G, Fabbretti G, Brisigotti M, Stefanelli ML, Gasbarrini A.

World J Gastroenterol. 2016 Dec 14;22(46):10198-10209. doi: 10.3748/wjg.v22.i46.10198.

Supplemental Content

Loading ...
Support Center